Assistant Professor, Urology, UCLA School of Medicine
Urology
Dr. Isla P. Garraway, MD
|
|
Give Review
Isla Garraway practices Urology. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care He over the years received 1 awards: "Super Doctor". Doctor Isla P. Garraway, MD is a published doctor. He has 18 publications published. The most current publication "Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure."
Publications
- Differential gene expression profiling of functionally and developmentally distinct human Prostate epithelial populations.
- Targeting the RANKL Pathway: Putting the Brakes on Prostate Cancer Progression in Bone.
- Cell autonomous role of PTEN in regulating castration-resistant prostate Cancer growth.
- Identification of a cell of origin for human prostate Cancer.
- Absent CD44v6 expression is an independent predictor of poor urothelial Bladder cancer outcome.
- Human Prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo.
- Trop2 identifies a subpopulation of mUrine and human prostate basal cells with stem cell characteristics.
- Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human Bladder cancer cell lines.
- Epithelial stem cells of the prostate and their role in Cancer progression.
- Case scenario: 26-year-old Male with right scrotal pain and swelling.
- Current treatment options for penile fractures.
- Trefoil factor 3 is overexpressed in human prostate Cancer.
- Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator.
- The initiator element: a paradigm for core promoter heterogeneity within metazoan protein-coding genes.
- Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure.
- Mechanism of initiator-mediated transcription: evidence for a functional interaction between the TATA-binding protein and DNA in the absence of a specific recognition ...
- Multidisciplinary intervention of early, lethal metastatic prostate Cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.
Schools
University of California At Los Angeles
UCLA Med CtrUCLA D Geffen School
Procedures Preformed
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Uroflowmetry
Conditions Treated
- Bladder Cancer
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- Enlarged Prostate (BPH)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Super Doctor
Education
-
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Philip A. Yalowitz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Ehrlich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siamak Daneshmand, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Howard H. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry J. Campbell, MD |
|
|
Dr. Charles D. Best, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen D. Bloomberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raed A. Azhar, MD |
|
|
Dr. Shelby N. Morrisroe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew S. Behesnilian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph M. Gleason, MD |
|
|
Dr. Mukul B. Patil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ali-Asghar Zhumkhawala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Osamu Ukimura, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|